Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Zerodha CASE Nifty Next 100 ETF · Direct ✕Nippon India Nifty Pharma ETF · Direct ✕

Growth of ₹10,000

Basics

Zerodha CASE Nifty Next 100 ETFNippon India Nifty Pharma ETF
CategoryEquity ETFsEquity ETFs
PlanDirectDirect
Fund houseZerodhaNippon India
NAV₹10.8050₹29.1863
NAV date20 Nov 202620 Nov 2026
History1 months5.4 years
Expense ratio1.8%0.2%
StarsNot ratedNot rated
Growth Score——

Returns

Zerodha CASE Nifty Next 100 ETFNippon India Nifty Pharma ETF
1 month+6.69%+10.82%
3 months—+7.43%
6 months—+14.54%
YTD—+25.40%
1 year—+25.57%
3 years (CAGR)—+22.02%
5 years (CAGR)—+16.60%
10 years (CAGR)——
Since launch+5.74%+14.02%

Risk

Zerodha CASE Nifty Next 100 ETFNippon India Nifty Pharma ETF
Volatility—15.0%
Downside volatility—9.0%
Sharpe—1.04
Sortino—1.72
Calmar—1.33
Return / risk—1.47
Deepest fall−4.90%−20.98%
Days to recover11136
Below its high+0.00%−1.75%

Against benchmark

Zerodha CASE Nifty Next 100 ETFNippon India Nifty Pharma ETF
Alpha—+0.00%
Beta—1.00
R²—100.0%
Up capture—100.0%
Down capture—100.0%
Tracking error—0.0%
Information ratio——
Treynor—0.14

Consistency

Zerodha CASE Nifty Next 100 ETFNippon India Nifty Pharma ETF
Best 1-year—+65.21%
Middle 1-year—+13.46%
Worst 1-year—−15.30%
1-year periods with a loss—25.8%
Middle 3-year—+20.51%
Positive months—61.1%
Best day—+3.64%
Worst day—−4.03%
Worst 5% day—−1.62%
Positive days—54.4%
NAVs a year—248

SIP of ₹10,000 a month

Zerodha CASE Nifty Next 100 ETFNippon India Nifty Pharma ETF
5-year XIRR—+20.60%
5-year value—₹10,11,738
3-year XIRR—+19.58%
1-year XIRR—+34.31%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth